Advertisement

diagnostics

diagnostics

Extracellular Vesicles as Breast Cancer Biomarkers

News, Scientific Articles|

Triple-negative breast cancer is particularly aggressive, challenging to treat, and accounts for 15-20% of all breast cancers. In this blog, we review a study published in Nature Communications that examines the transforming growth factor-β targetable signaling pathway, its role in malignant cancer progression and immune suppression, and tumor-derived extracellular vesicles as diagnostic and prognostic biomarkers.

Go to Top